ResearcherVilnius UniversityNo recent work listed
Kęstutis Strupas
Matched on ORCID iD 0000-0002-1690-937X; OpenAlex author ID A5088230342. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 2 papers
Papers 6
- The Impact of Epithelial-Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy. Co-author DOI 10.3390/medicina58040467↗
- Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Factors-Literature Review. Co-author DOI 10.3390/medicina58060756↗
- Heat Shock Protein 90 Inhibitor Effects on Pancreatic Cancer Cell Cultures. Co-author DOI 10.1097/mpa.0000000000001807↗
- Towards a Personalized Approach in Pancreatic Cancer Diagnostics Through Plasma Amino Acid Analysis. Co-author DOI 10.21873/anticanres.13314↗
- Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer. Last author DOI 10.21873/anticanres.12914↗
- Differential diagnosis between chronic pancreatitis and pancreatic cancer: a prospective study of 156 patients. Last author DOI 10.3390/medicina47020021↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Aistė Gulla · 3 shared papers, 2021–2022 · strength 0.52
- Paper The Impact of Epithelial-Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards I… DOI 10.3390/medicina58040467↗
- Paper Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Fac… DOI 10.3390/medicina58060756↗
- Paper Heat Shock Protein 90 Inhibitor Effects on Pancreatic Cancer Cell Cultures. DOI 10.1097/mpa.0000000000001807↗
- Audrius Šileikis · 2 shared papers, 2018–2019 · strength 0.20
- Sohei Satoi · 1 shared paper, 2022 · strength 0.19
- Daisuke Hashimoto · 1 shared paper, 2022 · strength 0.19
- Helena M. Kelly · 1 shared paper, 2022 · strength 0.19
- James R. Eshleman · 1 shared paper, 2021 · strength 0.15
- Jaroslav Tumas · 1 shared paper, 2019 · strength 0.11
- Marija Ger · 1 shared paper, 2018 · strength 0.09
- Benediktas Kurlinkus · 1 shared paper, 2018 · strength 0.09
- Mindaugas Valius · 1 shared paper, 2018 · strength 0.09
- Jonas Cicenas · 1 shared paper, 2018 · strength 0.09
- Vilma Brimienė · 1 shared paper, 2011 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.